Dextenza for Post-operative Treatment of Pterygium — PERSIST

Pterygium of Both Eyes Clinical Trial

Official title:
DEXTENZA for the Treatment of Post-Surgical Pain and Inflammation ComparEd to StandaRd of Care Topical Cortico-Steroid Treatment In PatientS Who Undergo BilaTeral Pterygium Surgery PERSIST Study

Status Active, not recruiting

Clinical Trial Summary

DEXTENZA for the Treatment of Post-Surgical Pain and Inflammation Compared to Standard of Care Topical Cortico-steroid Treatment in Patients who Undergo Bilateral Pterygium Surgery

Clinical Trial Description

In patients who undergo bilateral pterygium surgery, eyes will be randomized to receive either DEXTENZA at baseline, Month 1 and Month 2 or prednisolone x 3 months. Both eyes will receive antibiotic drops four times per day for two weeks and Maxitrol ointment at bedtime for two weeks following surgery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04351737
Study type	Interventional
Source	Brandon Eye Associates, PA
Contact
Status	Active, not recruiting
Phase	Phase 4
Start date	July 15, 2020
Completion date	July 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06402643` - Comparison of Recurrence Between Mini-SLET and Limbal-Conjunctival Autograft Techniques in Primary Pterygium	N/A
Completed	`NCT04385446` - Comparative Study of Muc5ac and Muc2 Mucins in Tear Film Concentration in Surgical Treated Pterygia Patients	N/A
Not yet recruiting	`NCT04151862` - The Two Most Common Ways Post-operative Eye Patch Are Therapeutic Contact Lenses (TCL) and Overnight Bandaging With Tight Bandage Patch: This Study is Designed to Determine the Most Effective Post-operative Care to Relief the Patient's Discomfort After Pterygium Excision Surgery	N/A